Trial record 1 of 64 for:    (domestic or partner) AND (violence OR abuse)
Previous Study | Return to List | Next Study

Treatment of Intimate Partner Violence and Substance Abuse in a Forensic Setting

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Paul M.G.Emmelkamp, VU University of Amsterdam
ClinicalTrials.gov Identifier:
NCT00847548
First received: February 18, 2009
Last updated: September 16, 2013
Last verified: September 2013
  Purpose

Intimate partner violence is a significant societal problem. However, treatment of IPV perpetrators is far from effective, which may be partly due to the fact that the role of substance abuse is not taken into account. There is considerable evidence that a strong relationship between the use of alcohol and other drugs and intimate partner violence exists. Besides, a few studies indicate that reducing substance use may have a positive impact on IPV. Therefore, in this study, perpetrators of intimate partner violence with substance use disorders enrolled in domestic violence treatment will be randomly assigned to either standard treatment for offenders of domestic violence or a combination of the latter treatment with cognitive-behavioral therapy addressing substance abuse (combined treatment).


Condition Intervention
Domestic Violence
Substance Abuse
Behavioral: substance abuse/domestic violence treatment
Behavioral: CBT addressing partner violence

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Treatment of Intimate Partner Violence and Substance Abuse in a Forensic Setting

Resource links provided by NLM:


Further study details as provided by VU University of Amsterdam:

Primary Outcome Measures:
  • Quick Drinking Screen (QDS) [ Time Frame: pretest, posttest, 6 & 12 months follow-up ] [ Designated as safety issue: No ]
  • Conflict Tactics Scale (CTS) [ Time Frame: pretest, halfway treatment, posttest, 6 & 12 months follow-up ] [ Designated as safety issue: No ]
  • Timeline Followback interview [ Time Frame: pretest, posttest ] [ Designated as safety issue: No ]
    Assesses daily substance use in the past 4 months


Secondary Outcome Measures:
  • Brief Symptom Inventory (BSI) [ Time Frame: pretest, posttest, 6 and 12 moths follow-up ] [ Designated as safety issue: No ]
    Assesses general psychological complaints

  • Maudsly Marital Questionnaire (MMQ) [ Time Frame: pretest, posttest, 6 and 12 months follow up ] [ Designated as safety issue: No ]
    Assesses marital satisfaction


Estimated Enrollment: 100
Study Start Date: September 2010
Estimated Study Completion Date: April 2014
Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: combined treatment
A combined treatment containing cognitive behavioral therapy addressing partner violence and cognitive behavioral therapy addressing substance abuse
Behavioral: substance abuse/domestic violence treatment
This intervention is comprised of 16 sessions of cognitive behavioral therapy. 8 sessions are addressing partner violence and 8 sessions are addressing substance abuse.
Active Comparator: control condition
Cognitive behavioral therapy addressing partner violence
Behavioral: CBT addressing partner violence
This treatment is comprised of 16 sessions of cognitive behavioral therapy addressing partner violence.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • A history of perpetration of intimate partner violence
  • Current alcohol, cannabis and/or cocaine abuse or dependence
  • Still in an intimate relationship with the victim

Exclusion Criteria:

  • Not sufficient fluency in Dutch to complete treatment and measures
  • (ab)use of crack cocaine and/or heroin
  • In need of clinical detoxification
  • Severe mental disorders, such as psychosis
  • Severe cognitive disorders, such as Korsakoff's syndrome
  • In treatment for other mental health problems
  • Abuse of children
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00847548

Locations
Netherlands
De Waag Amsterdam & Rijnmond
Amsterdam / Rotterdam, Netherlands, 1018AJ
Sponsors and Collaborators
VU University of Amsterdam
Investigators
Principal Investigator: Paul M.G. Emmelkamp, PhD. VU University of Amsterdam
  More Information

No publications provided

Responsible Party: Paul M.G.Emmelkamp, Prof. Dr. P.M.G. Emmelkamp, VU University of Amsterdam
ClinicalTrials.gov Identifier: NCT00847548     History of Changes
Other Study ID Numbers: 2008-KP-463
Study First Received: February 18, 2009
Last Updated: September 16, 2013
Health Authority: Netherlands: Independent Ethics Committee

Keywords provided by VU University of Amsterdam:
intimate partner violence
domestic violence
substance abuse
alcohol abuse
drug abuse
addiction

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on September 14, 2014